March 18, 2026
Akash Gupta, a research scientist known for developing advanced delivery systems for cancer immunotherapies while working at MIT, will join the University of Houston to develop new platforms for cancer immunotherapies, initially focusing on lung cancer. His recruitment is supported by the Cancer Prevention and Research Institute of Texas.